Open in app

Sign in

Write

Sign in

Acuity Knowledge Partners
Acuity Knowledge Partners

84 Followers

Home

Lists

About

4 days ago

The Revised Market Risk Framework (FRTB): How much is too much?

Risk regulations as well as financial reporting require banks to measure expected loss for its products. Though obvious synergies are expected between their measurements in Basel III and IFRS 9, the usability of components from one to the other would require significant adjustments. The European Banking Authority is working towards bridging this gap between Risk and Finance functions within banks. EBA, in its guidelines on 26th July 2016, intends to follow Basel Committee of Banking Supervision’s supervisory guidance on ensuring sound credit risk management practices on implementing and applying IFRS 9 impairment models.

Revised Market Risk

1 min read

Revised Market Risk

1 min read


4 days ago

Quality of Earnings Review — Identifying the Fat Tail

Failing to review the quality of earnings of your underlying investments is similar to investing in derivative instruments. Learn why quality of earnings reviews are important in the investment due diligence process and identify common tricks used by some executives to distort earnings. We present quality of earnings red flags, which act as early warning indicators. The webinar also presents our experience in carrying out quality of earnings reviews. We take you through some of our experiences — including highlights from a review a couple of years before it made headlines

Earnings Review

1 min read

Earnings Review

1 min read


4 days ago

Therapeutic cancer Vaccines the way forward

Event Summary The cancer-treatment landscape is changing rapidly from conventional chemo and hormonal therapy to targeted therapy, and is finally set to move towards cancer immunotherapy amid increasing competition. Therapeutic cancer vaccines are a potential game changer, with established proof of concept. Learn about the developmental strategies of these therapies and the challenges pharmaceutical companies face in translating the promising approach into clinically feasible therapies.

Therapeutic Cancer

1 min read

Therapeutic Cancer

1 min read


4 days ago

Challenges in Model Risk Management

Financial firms rely on quantitative models for a broad range of business decisions. In recent years, banks have increased their reliance on sophisticated quantitative models to navigate through the maze of ever-evolving new and complex regulations, which has exposed them to model risk in the current dynamic business environment. Key Takeaways Financial firms rely on quantitative models for a broad range of business decisions. In recent years, banks have increased their reliance on sophisticated quantitative models to navigate through the maze of ever-evolving new and complex regulations, which has exposed them to model risk in the current dynamic business environment.

Model Risk Management

1 min read

Model Risk Management

1 min read


4 days ago

Rethinking Research Publishing: Offshoring Supervisory Analyst Review

Event Summary As the Investment Research business grapples with a structural contraction in cash equities volumes, disruptions from MiFID II and other regulations, the sell side is rethinking how to manage costs of producing research without compromising on the quality of content that reaches investors. Research Publishing costs represent a sizeable portion of the cost to run a high-quality global sell-side research team. The Research Publishing workflow also has its own unique set of operational challenges in terms of peaks and troughs.

Research Publishing

1 min read

Research Publishing

1 min read


4 days ago

Spinning the ‘RARE Wheel’

Event Summary ‘RARE’ is becoming the new common as these life-threatening diseases are affecting larger populations, with 6.5 to 10 cases in every 10,000 people as defined by the WHO. Last decade witnessed the researchers raring to spin the RARE wheel. Numbers suggest that this area is a promising ‘mining opportunity’ But, to mine out a viable product, it is imperative to find answers to tough questions that some of the major pharmaceutical companies seem to be grappling with; most important being — “how to ensure optimal ROI from investments in orphan drugs while navigating through a complex maze of regulatory and pricing challenges?”

Rare Wheel

1 min read

Rare Wheel

1 min read


4 days ago

Uberisation of Lending: How Banks can stay ahead of the Curve

Event Summary The banking industry is undergoing a transformation as banks are facing increased competition from alternatives, such as shadow banks, challenger banks, and new-age FinTech firms. According to market data sources, the total assets of nonbank lenders have surpassed $18 tn, ahead of commercial banks’ $16 tn. Lenders are…

Uberisation Of Lending

1 min read

Uberisation Of Lending

1 min read


4 days ago

Unlock the Potential of your Research Data

Event Summary Grappling with an overload of research data? Have you considered centralizing research data to facilitate idea generation, foster collaboration, and significantly enhance the productivity of your in-house investment research teams? As you can imagine, the benefits are multifold. However, implementing such an initiative and driving adoption poses significant challenges to asset managers globally.

Research Data

1 min read

Research Data

1 min read


4 days ago

Unlocking Alpha with Alternative Data: Generating Unique Investment Insights

Event Summary In the last decade, the world witnessed dramatic changes in technology and considerable pressure from global regulatory bodies. This, coupled with a highly competitive global landscape and pressure on margins, has led firms to focus on exploring new avenues of alpha generation or product differentiation. Global internet traffic…

Alternative Data

1 min read

Alternative Data

1 min read


4 days ago

The future of marketing and reporting: Empowering asset managers in the transformation journey

Event Summary Global asset managers are finding it increasingly challenging to stay ahead of their peers. This webinar focuses on how important it is for marketing and client-servicing teams to recognize the evolution of fund collateral dynamics in conjunction with digital transformation. Laurie will provide insights into the changing marketing and client-servicing landscape and challenges in the asset management industry. She will also address how, with widespread use of technology, asset management firms are looking at merging man and machine without losing sight of ROI. The webinar will also cover the role of a knowledge services partner and how managed solutions can meet the challenge of blending technology with talent.

Marketing And Reporting

1 min read

Marketing And Reporting

1 min read

Acuity Knowledge Partners

Acuity Knowledge Partners

84 Followers

We write about financial industry trends, the impact of regulatory changes and opinions on industry inflection points. https://bit.ly/3NaJ4Et

Following
  • Scott Galloway

    Scott Galloway

  • Alberto García 🚀🚀🚀

    Alberto García 🚀🚀🚀

  • Fabric Ventures

    Fabric Ventures

  • Peteris Erins

    Peteris Erins

  • Pantera Capital

    Pantera Capital

See all (30)

Help

Status

About

Careers

Blog

Privacy

Terms

Text to speech

Teams